Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2024 | What challenges are there in using CAR-T cells for solid tumors?

Leonardo Ferreira, PhD, The Medical University of South Carolina (MUSC), Charleston, SC, gives an overview of issues relating to the use of CAR-T cells for solid tumors. Unlike in liquid tumors, solid tumors have a more immunosuppressive tumor microenvironment, and T-cell exhaustion is a common occurrence. Low oxygen, glucose and glutamine can also reduce the efficacy of CAR-T cells, as well as physical barriers such as the extracellular matrix. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.